Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006.

BACKGROUND Hemolytic uremic syndrome (HUS) is a life-threatening illness usually caused by infection with Shiga toxin-producing Escherichia coli O157 (STEC O157). We evaluated the age-specific rate of HUS and death among persons with STEC O157 infection and the risk factors associated with developing HUS. METHODS STEC O157 infections and HUS cases were reported from 8 sites participating in the Foodborne Diseases Active Surveillance Network during 2000-2006. For each case of STEC O157 infection and HUS, demographic and clinical outcomes were reported. The proportion of STEC O157 infections resulting in HUS was determined. RESULTS A total of 3464 STEC O157 infections were ascertained; 218 persons (6.3%) developed HUS. The highest proportion of HUS cases (15.3%) occurred among children aged <5 years. Death occurred in 0.6% of all patients with STEC O157 infection and in 4.6% of those with HUS. With or without HUS, persons aged 60 years had the highest rate of death due to STEC O157 infection. Twelve (3.1%) of 390 persons aged 60 years died, including 5 (33.3%) of 15 persons with HUS and 7 (1.9%) of 375 without. Among children aged <5 years, death occurred in 4 (3.0%) of those with HUS and 2 (0.3%) of those without. CONCLUSIONS Young children and females had an increased risk of HUS after STEC O157 infection. With or without HUS, elderly persons had the highest proportion of deaths associated with STEC O157 infection. These data support recommendations for aggressive supportive care of young children and the elderly early during illness due to STEC O157.

[1]  E. Scallan Activities, achievements, and lessons learned during the first 10 years of the Foodborne Diseases Active Surveillance Network: 1996-2005. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  E. Keeffe,et al.  Escherichia Coli O157:H7 Infection in Nursing Homes: Review of Literature and Report of Recent Outbreak , 2006, Journal of the American Geriatrics Society.

[3]  D. Morse,et al.  Hemolytic Uremic Syndrome Risk and Escherichia coli O157:H7 , 2005, Emerging infectious diseases.

[4]  P. Tarr,et al.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome , 2005, The Lancet.

[5]  D. Morse,et al.  Hemolytic Uremic Syndrome Incidence in New York , 2004, Emerging infectious diseases.

[6]  C. Hedberg,et al.  Factors affecting surveillance data on Escherichia coli O157 infections collected from FoodNet sites, 1996-1999. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  J. Wells,et al.  Laboratory practices for stool-specimen culture for bacterial pathogens, including Escherichia coli O157:H7, in the FoodNet sites, 1995-2000. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  J. H. Green,et al.  The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. , 2001, The Journal of infectious diseases.

[9]  H. Lior,et al.  Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: results of a Canadian collaborative study. Investigators of the Canadian Pediatric Kidney Disease Research Center. , 1998, The Journal of pediatrics.

[10]  B. Bell,et al.  Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. , 1997, Pediatrics.

[11]  J. Wells,et al.  Escherichia coli 0157 : H 7 Diarrhea in the United States : Clinical and Epidemiologic Features , 2009 .

[12]  N. Cimolai,et al.  A continuing assessment of risk factors for the development of Escherichia coli O157:H7-associated hemolytic uremic syndrome. , 1994, Clinical nephrology.

[13]  R. Christofferson,et al.  A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah. , 1994, Pediatrics.

[14]  E. Orrbine,et al.  Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988. The Canadian Pediatric Kidney Disease Reference Centre. , 1991, The Journal of pediatrics.

[15]  H. Lior,et al.  Haemolytic anaemia after childhood Escherichia coli O 157.H7 infection: are females at increased risk? , 1991, Epidemiology and Infection.

[16]  P. Tarr,et al.  Escherichia coli 0157:H7 and the Hemolytic Uremic Syndrome: Importance of Early Cultures in Establishing the Etiology , 1990 .

[17]  J. Anderson,et al.  Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome. , 1990, The Journal of pediatrics.

[18]  S. Ostroff,et al.  Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance. , 1989, JAMA.

[19]  J. Carlson,et al.  A severe outbreak of Escherichia coli O157:H7--associated hemorrhagic colitis in a nursing home. , 1987, The New England journal of medicine.

[20]  S. Cutillo [Hemolytic-uremic syndrome]. , 1973, La Pediatria.